Hand-out
Press Releases
December 13, 2024
FDA Approves New Treatment for Congenital Adrenal Hyperplasia
SILVER SPRING, Md., Dec. 13, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Crenessity (crinecerfont) to be used together with glucocorticoids (steroids) to control androgen (a testosterone-like
